文献速递消化、代谢与肾脏急症呼吸衰竭与机械通气重症综合管理与镇静镇痛

改良急诊严重指数分级与COVID-19癌症患者结局相关

A modified emergency severity index level is associated with outcomes in cancer patients with COVID-19.
PubMed 文献 · Am J Emerg Med · 2022-02-05
一句话结论在COVID-19癌症患者中,改良急诊严重指数(mESI)分级与急诊去向、急诊停留时间和总生存相关,mESI可作为分诊工具用于这类可能迅速恶化的患者。

该研究回顾性分析了2020年3月22日至2021年3月12日期间在本机构急诊就诊且SARS-CoV-2检测阳性的306例癌症患者,按mESI分诊为2级(紧急)45%和3级(急症)55%。结果显示,紧急组急诊停留时间6.67 h vs 急症组5.97 h(p<0.01),紧急组住院率和ICU入住率均显著高于急症组(p<0.05),30天死亡率紧急组15% vs 急症组8%(p<0.05)。多因素分析中mESI分级仍是总生存的显著相关因素(HR=1.7,95%CI 1.09-2.81)。作者认为mESI分诊工具可有效用于病情可能迅速恶化的COVID-19癌症患者。

要点

  • 306例COVID-19癌症患者中45%分诊为mESI 2级(紧急)、55%为3级(急症),两组人口学和临床特征无显著差异。
  • 紧急组急诊停留时间6.67 h vs 急症组5.97 h(p<0.01),紧急组住院率和ICU入住率均显著更高(p<0.05)。
  • 30天死亡率紧急组15% vs 急症组8%(p<0.05),全组共75例死亡(紧急组43例、急症组32例)。
  • 多因素分析中mESI分级与总生存显著相关(HR=1.7,95%CI 1.09-2.81)。
  • 作者认为mESI分诊工具可有效用于病情可能迅速恶化的COVID-19癌症患者。

适用人群与场景

  • 2020年3月22日至2021年3月12日期间在本机构急诊就诊且SARS-CoV-2检测阳性的癌症患者,共306例。

研究设计与关键结果

  • 回顾性研究,共纳入306例SARS-CoV-2阳性的癌症患者;45%分诊为mESI 2级(紧急),55%为3级(急症)。
  • 全组61.8%住院,15.7%入住ICU,2.9%留观,19.6%离院。
  • 人口学和临床特征在分诊级别间无显著差异。
  • 急诊停留时间:急症组6.67 h vs 紧急组5.97 h(p<0.01)。
  • 紧急组住院率和ICU入住率均显著高于急症组(p<0.05)。
  • 全组共75例死亡(急症组32例、紧急组43例);30天死亡率紧急组15% vs 急症组8%(p<0.05)。
  • 多因素分析中mESI分级与总生存显著相关(HR=1.7,95%CI 1.09-2.81)。

证据类型、等级与局限

  • 回顾性研究(单中心,原文自述为本机构急诊病历回顾)。

对床旁实践的改变

  • 作者认为mESI分诊工具可有效用于病情可能迅速恶化的COVID-19癌症患者。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: To evaluate a modified emergency severity index (mESI)-based triage of cancer patients with coronavirus disease 2019 (COVID-19) in the emergency department (ED) and determine the associations between mESI level and ED disposition, hospital length of stay, and overall survival.

METHODS: Medical records were retrospectively reviewed for all patients who presented to our institution's ED between March 22, 2020, and March 12, 2021, and tested positive for SARS-CoV-2.

RESULTS: A total of 306 cancer patients tested positive for SARS-CoV-2, with 45% of patients triaged to level 2 (emergent) and 55% to level 3 (urgent). Among all patients, 61.8% were admitted to the hospital, 15.7% were admitted to the intensive care unit, 2.9% were sent for observation, and 19.6% were discharged. Although demographic and clinical characteristics did not significantly vary by triage level, we observed significant differences in ED length of stay (urgent = 6.67 h, emergent = 5.97 h; p < 0.01). Hospital and intensive care unit admission rates were also significantly higher among emergent patients than among urgent patients (p < 0.05). There were 75 deaths (urgent = 32; emergent = 43), and the 30-day mortality rate was significantly higher among emergent patients (urgent = 8%, emergent = 15%; p < 0.05). The mESI level persisted as a significant factor associated with overall survival (hazard ratio = 1.7, 95% confidence interval = 1.09-2.81) in multivariable analysis.

CONCLUSION: The mESI level is associated with ED disposition, ED length of stay, and overall survival in cancer patients presenting with COVID-19. These results indicate that the mESI triage tool can be effectively used in cancer patients with COVID-19, whose condition can rapidly deteriorate.

来源:Am J Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Lipe DN, Bourenane SS, Wattana MK, et al. A modified emergency severity index level is associated with outcomes in cancer patients with COVID-19. Am J Emerg Med. 2022. PMID: 35152119. doi:10.1016/j.ajem.2022.02.002

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。